Abstract:OBJECTIVE:To detect the preoperative chemoradiotherapy sensitivity molecular characteristics of rectal cancer by transcriptome second generation sequencing.METHODS:The clinicopathological data of 30 patients with locally advanced rectal cancer were collected prospectively, including 9 indicators (general conditions, imaging data before radiotherapy and chemotherapy, pathological data of biopsy before radiotherapy and chemotherapy, and tumor differentiation degree, etc.), in order to analyze the correlation between them and tumor regression grading (TRG) after radiotherapy and chemotherapy for rectal cancer. At the same time, frozen specimens of colonoscopy biopsy before neoadjuvant therapy were collected from these 30 patients, and transcriptome second-generation sequencing was performed for bioinformatics analysis to screen out the genes that might drive the radio chemotherapy sensitivity of rectal cancer.RESULTS:Among the 30 patients with rectal cancer, 9 had complete pathological remission, 12 had partial remission, and 9 had poor remission. The degree of pathological TRG remission after radiotherapy and chemotherapy for rectal cancer was negatively correlated with the preoperative MRI T stage (P=0.046), and positively correlated with preoperative MRI rectal cancer extravascular invasion (EMVI) (P=0.003). Transcriptome second-generation sequencing of the obtained 217 transcripts (P<0.05) for signal pathway enrichment analysis, and multiple cell signal transduction pathways related to antigen presentation could be found. The high expression of HSPA1A, HSPA1B and EXOSC2 was positively correlated with postoperative pathological remission (P<0.05). The high expression of DNMBP, WASH8P, FAM57A, and SGSM2 was positively correlated with postoperative pathological remission (P<0.05).CONCLUSION:Preoperative NMR detection of extra-tumoral vascular invasion (EMVI-positive) in patients with rectal cancer was significantly better than that of EMVI-negative patients after chemoradiotherapy. Patients with high expressions of HSPA1A, HSPA1B and EXOSC2 had poor postoperative pathological remission, while patients with high expressions of genes, such as DMNMB, WASH8P, FAM57A, and SGSM2 had good postoperative pathological remission. Based on the molecular characteristics of rectal cancer radiotherapy and chemotherapy, attempts to block or enhance the molecular pathways associated with chemosensitivity of rectal cancer, are to be made to further explore new candidate therapeutic targets that can increase the sensitivity of radiotherapy and chemotherapy for rectal cancer.

DSTN hypomethylation promotes radiotherapy resistance of rectal cancer by activating the Wnt/β-catenin signaling pathway

DST Regulates Cisplatin Resistance in Colorectal Cancer Via PI3K/Akt Pathway

Hypermethylation of DMTN Promotes the Metastasis of Colorectal Cancer Cells by Regulating the Actin Cytoskeleton Through Rac1 Signaling Activation.

IDDF2024-ABS-0362 Dopamine Receptor 4 Hypermethylation: a Multi-Malignant Tumor Marker Plausible for Colorectal Cancer Screening Through Fecal DNA Testing

Inhibition of DNMT Suppresses the Stemness of Colorectal Cancer Cells Through Down-Regulating Wnt Signaling Pathway.

[The Role of Secreted Wnt-antagonist Genes Hypermethylation in Early Detection of Colorectal Tumor].

Inhibition of DNMTs increases neoantigen-reactive T-cell toxicity against microsatellite-stable colorectal cancer in combination with radiotherapy

[Detection of Preoperative Chemoradiotherapy Sensitivity Molecular Characteristics of Rectal Cancer by Transcriptome Second Generation Sequencing].

Comprehensive molecular exploration identified promoter DNA methylation of the CRBP1 gene as a determinant of radiation sensitivity in rectal cancer

Integrated Analysis of DNA Methylation and Mrna Expression Profiling Reveals Candidate Genes Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer.

Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer

ZNF37A Downregulation Promotes TNFRSF6B Expression and Leads to Therapeutic Resistance to Concurrent Chemoradiotherapy in Rectal Cancer Patients

Predictive Factors for the Sensitivity of Radiotherapy and Prognosis of Esophageal Squamous Cell Carcinoma

SUMO1 modification stabilizes TET3 protein and increases colorectal cancer radiotherapy sensitivity

A novel high-risk model identified by epithelial-mesenchymal transition predicts prognosis and radioresistance in rectal cancer

Investigating the role of disulfidptosis related genes in radiotherapy resistance of lung adenocarcinoma

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.

Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer

A systematic approach introduced some immune system targets in rectal cancer by considering cell-free DNA methylation in response to radiochemotherapy

Regulatory network of competitively interacting RNAs and effectiveness of rectal tumors radiotherapy

PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer